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IDENTIFICATION AND QUANTIFICATION OF BIOMARKERS TO CONFIRM THE POISONING BY GINKGO BILOBA SEEDS IN A 2-YEAR-OLD BOY
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Introduction
Ginkgo biloba (commonly known as ginkgo or Maindenhair tree) is an ancient tree with distinctive fan-shaped leaves, belonging to the family of Ginkgoaceae. Leaves and seeds are the parts most usually consumed, both as food (roasted or cooked seeds) and as extracts in food supplements and traditional medicines. The leaf extract is widely used in Europe as a traditional drug to improve the symptoms of early-stage Alzheimer's disease, vascular dementia, peripheral claudication and tinnitus of vascular origin. [1] [2] [3] [4] The adverse effects of Ginkgo biloba preparations containing leaves are numerous;
approximately 30% of these cases are due to interaction with therapeutic drugs, including acetyl salicylic acid, ibuprofen and warfarin. 5 The haemorrhagic complications, due to poisoning or interaction with prescription drugs, are probably due to the antiplatelet activity of ginkgosides, and in particular of Ginkgolide B 6 .
Ginkgo biloba seeds are commonly eaten in Japan, Korea and China for their nutritive value, but it is important to know that they can be responsible for poisoning, especially in young children. 7, 8 Even though they are infrequent, clinical cases of ginkgo seed poisoning show severe symptoms, including tonic or clonic convulsion, vomiting, irritability and loss of consciousness. [7] [8] [9] Poisoning by ginkgo seeds is due to the neurotoxic compound 4'O-methylpyridoxine (MPN), which is chemically related to vitamin B 6 and interfere with its biosynthesis, metabolism and function. The chemical structures of MPN and piridoxine are reported in Fig. 1 .
Ginkgo biloba seeds contain MPN at concentrations ranging between 170 and 400 mg/g of raw seeds. [10] [11] [12] [13] The toxin is relatively heat-resistant so that cooking or other treatments only partially inactivate it. [14] [15] [16] Kajiyama & Fujii (2002) 7 described a case of poisoning in a 2-year-old girl who showed unexplained convulsions with vomiting, diarrhoea and irritability. The event was associated with the ingestion of 50 to 60 roasted ginkgo seeds, as reported by the parents. Similarly, a case of poisoning was described in another 2-year-old girl who had eaten about 50 ginkgo seeds 4 hours before the onset of symptoms 7 and a case of poisoning with ginkgo nuts was observed in a healthy 36-year-old woman, who consumed 70-80 seeds cooked in a microwave oven. 9 The pathophysiologic mechanisms responsible for convulsions related to ginkgo poisoning are not fully understood. As known from in vivo studies, 4'-O-methylpyridoxine (MPN) competes with vitamin B 6 , which is a cofactor of glutamate decarboxylase; as a consequence, MPN indirectly inhibits the activity of this enzyme resulting in a decrease of the -aminobutyric acid (GABA) level in brain, which predisposes to convulsions. 9, 17, 18 The study reported in this paper describes a case of ginkgo poisoning which occurred in Switzerland in a 2-year-old boy, where the association with the ingestion of ginkgo seeds was confirmed by measuring biomarkers both in blood and urine.
Materials

Clinical data
A 23-months-old previously healthy male child of Asian origin experienced two afebrile tonic-clonic seizures for 15-30 seconds. He had had a 2-hour period of vomiting and somnolence. The parents reported that the child ingested an unknown amount of Ginkgo seeds 10 hours before the beginning of symptoms. The subsequent clinical course was uneventful with full recover. Blood samples were taken 14 and 20 hours after the ingestion of seeds, while urine was collected only 14 hours after intake. The patient's family consented to the publication of this case report.
Purified standards
4'-O-methylpyridoxine (MPN)
The toxin 4'-O-methylpyridoxine was not commercially available at the time of the study, so that we synthesized it ourselves according to the method described by Harris (1940) . 19 reflux and, after cooling to 0°C, filtered to give 4.1 g (37.5%) of the compound as a white solid; the final product was chemically characterized to confirm the identity, as described in Results and Discussion.
Ginkgolides
Reference standards for (-)-bilobalide and ginkgolides A, B, C were kindly supplied by PhytoLab (Vestenbergsgreuth, Germany).
Reagents
The reagents used in the study were: acetone for HPLC (Farmitalia Carlo Erba, Milano, Italia); Hercules, California, USA).
Methods
Quantification of 4'-O-methylpyridoxine (MPN) in serum
Preparation of standard solutions and serum sample
Aliquots of 1 mg of MPN were solubilised in 10 mL of 0.1 M HCl, the final concentration being 100 μg/mL. Further standards of 1 and 0.1 μg/mL (prepared by dilution in 0.1 M HCl) were added to a healthy volunteer's serum present in our seroteque ("blank" sample) to obtain the final concentrations of 4.5, 7.2, 13.5, and 27 ng/mL of MPN, which were used to prepare the test for linear regression.
Aliquots of 500 L of these solutions or of the blank/patient's serum were added to 500 L of acetone; the resulting solutions were thoroughly vortexed, and centrifuged at 2500 rpm for 5 minutes (Hermle Labortechnik GmbH, Wehingen, Germany). The supernatants were filtered through a 0.45 m syringe filter (VWR International, Fontenay-sous-Bois, France) and injected into the HPLC.
Chromatographic conditions
A HPLC method combined with fluorimetric detection was used for the rapid separation and quantification of 4'-O-methylpyridoxine (MPN) in the patient's serum and urine. The equipment consisted of an Intelligent PU-880 pump (Jasco, Tokyo, Japan), a fluorescence Detector FP-1520 (Jasco, Tokyo, Japan), a sample injection valve Rheodyne 7725 with 20 L loop (Cotati, California, USA), a column of Inertsil ODS-2, 125 x 4.6 mm, particle size 5 m (GL Sciences Inc., Tokyo, Japan).
ChromNAV software (Jasco, Tokyo, Japan) was used for integration. The analysis was performed by isocratic elution at a flow rate of 1 mL/min with the mobile phase: 0.1% heptafluorobutyric acid in water, and acetonitrile, 90:10 (v/v). The column was heated at 40°C, and the fluorescence detector was set at 290/400 nm (ex/em).
Method validation
The HPLC method has been validated as described in Results. The suitability of the chromatographic system was daily checked by using the ChromNAV software (Jasco, Tokyo, Japan).
Detection of ginkgosides and bilobalide in urine
Preparation of standard solutions
Aliquots of 1 mg of each standard (ginkgolides A,B, C and bilobalide) were dissolved in 10 mL of water to a final concentration of 100 μg/mL. Dilutions were carried out in order to obtain a final mixture containing 10 µg/mL of each standard.
Sample preparation
The urine sample was prepared according to Dew et al., (2014) . 20 It was thawed at room temperature immediately before extraction, placed in an ultrasonic water bath (5 min The gradient elution was set up as shown in Table 1 . The autosampler and column oven temperatures were set at 8°C and 35°C, respectively, and the injection volume was 20 µL. MS analysis was performed in negative ionization mode. The capillary temperature was 300°C, the nebulized gas was nitrogen, sheath gas flow was 50 arb and sweep gas flow was 10 arb.
Results and discussion
Consumption of Ginkgo biloba seeds is quite common in Asian cuisine and in Oriental countries with a normally rather low risk. Traditionally, the seeds are roasted or boiled to reduce the activity of the neurotoxin, 4'-O-methylpyridoxine. Because of the rapid diffusion of oriental cuisine in other countries, the risk could be greater there from the unsuitable intake of ginkgo seeds. Both authorities and the population should be carefully informed of this possibility. To our knowledge, the case of gingko seed poisoning described in this paper is the first to occur in Europe.
The objectives of this work were: 1) to confirm the suspected intoxication by Ginkgo biloba seeds; 2)
to develop accurate methods of measuring biomarkers useful in identifying similar events in the future.
In fact, because of the severity of symptoms and the prevalent involvement of children, a clear methodological approach is necessary to allow rapid diagnosis and treatment.
In this case, a 23-months-old male child was brought to the emergency department after tonic-clonic seizures in both arms, and after discussion with the parents we hypothesized that the cause was intoxication by Ginkgo biloba seeds, so that serum and urine were collected and immediately sent for biomarker analysis.
On the basis of the paper by Hori et al (2004) , 10 a HPLC method for detection of the neurotoxin MPN was set up, with some modifications as described in Methods. Because purified MPN was not available, we synthesized it, as described in Materials and Methods. The final product was checked for quality and purity. Purity of 4'O-methyl pyridoxine was 90%, the remaining 10% being the pyridoxine used as a starting reagent in the synthetic procedure. Since pyridoxine did not interfere with the analysis, this standard was used as a reference compound for quantification, and a correction factor for purity was applied. A problem arose during the setting up of the method was the different performance shown by MPN standard in water/buffer solutions, compared to human serum or urine. For this reason the linear regressions were prepared in human serum/urine.
Validation of the method used for the quantification of 4'-O-methylpyridoxine (MPN) in serum
The method for the quantification of MPN in serum was validated according to the guidelines described by Peters et al. (2007), 21 for the following parameters: selectivity, linearity, accuracy, precision and sensitivity (LOD and LOQ). Furthermore, the System Suitability Test (SST) was performed according to the current FDA Guidelines on Bioanalytical Method Validation. 22 
System suitability test (SST)
The following parameters were calculated using the ChromNAV software: retention factor (K), separation factor between two neighbouring peaks (), peak tailing factor and column efficiency (number of theoretical plates). The analysis was performed in triplicate. Table 2 shows the results of the SST obtained from the analysis of the "blank" serum spiked with MPN at the final concentration of 30 ng/mL.
The parameters show that the chromatographic system used in this assay was highly efficient and suitable for the quantification of MPN, having retention factor (K) ≥ 2, separation factor () > 1, symmetry factor (SF) < 2.
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Selectivity
The possible interaction between analytes and endogenous matrix components was investigated by adding standard MPN to the "blank" serum (final 30 ng/mL). Peak areas of compounds coeluting with the analytes should be less than 20% of the peak area of sample at LOQ. As shown in Fig. 2 , MPN can be clearly identified; no peak at the retention times of MPN had an area exceeding 20% at LOQ values.
Linearity
Standard solutions (1 and 0.1 g/mL) were added to a "blank" serum to have final concentration of 5, 8, 15 and 30 ng/mL; these solutions were prepared as described in "sample preparation" (3.2.2) and analysed with three independent injections.
Linear regression was obtained by plotting the areas of analyte peaks vs the nominal concentrations.
The calibration curve equation and the corresponding correlation coefficient (R 2 ) were calculated taking into account the purity of the standard (90%). The linear regression, used to calculate MPN concentrations in serum is illustrated in Fig. 3 . The method was linear between 4.5 and 27 ng/mL, as shown by the correlation coefficient (R 2 ) higher than 0.99. The linear regression equation was y=13872X+23918, where y refers to the peak area and x refers to concentration.
Accuracy and precision
Accuracy and precision were determined spiking "blank" serum samples with two concentrations of the MPN standard (0.1 and 1 µg/mL) in order to have final concentrations at 6 and 25 ng/mL (corresponding to actual concentrations of MPN of 5.4 and 22.5 ng/mL, respectively).
Accuracy was calculated as the percent of variation between the experimentally measured means and the nominal values. Precision was determined by calculating the variation coefficient (RSD%) of the peak areas of five replicates injected in the same day. Table 3 shows the results obtained for accuracy and precision. Being RSD% <15%, the method must be considered precise, and since the calculated accuracy was always within ±15% of the nominal concentration, the method can be considered accurate.
Sensitivity (LOD and LOQ)
The sensitivity of the analytical method was evaluated by determining the limit of detection (LOD) and the limit of quantification (LOQ). LOD and LOQ were determined spiking "blank" serum samples with decreasing concentrations of MPN standard: LOD was established at a signal-to-noise ratio of 3 and LOQ at a signal-to-noise ratio of 10. The LOQ was based on data obtained from 5 independent injections.
LOD and LOQ for MPN measured in the "blank" serum were 1.35 and 4.5 ng/mL, respectively. The precision at LOQ was 13.9%, below the acceptable limit of 15%. All values reported above were suitable for an accurate determination of MPN in serum samples. Ginkgolide A and C were present in concentrations close to 1 and 2 g/mL, respectively. Bilobalide was not detectable.
Quantification of 4'-O-methylpyridoxine (MPN) in serum and urine
Conclusions
The case described in this paper shows that the poisoning due to Ginkgo biloba seeds must be considered as a possible clinical event also in European countries, where Asian cuisine has received a relatively recent popularity. Any introduction of new dietetic habits requires suitable information to be provided, as in the case of Ginkgo biloba seeds, which are appreciated also by children for their good flavour. Unfortunately, particularly for the youngest children they could represent a risk, as shown by case reports published in the scientific literature. 7, 8 In the case described here, poisoning was confirmed by identifying biomarkers both in blood and urine. Traditionally, 4'-O-methylpyridoxine (MPN) has been considered as the specific biomarker for ginkgo seed poisoning, both in blood and urine.
Considering the different papers reporting cases of ginkgo seed poisoning (Table 4) , it quite evident the difficulty in correlating the number of seed ingested with MPN serum concentration; moreover, the kinetic of MPN in serum and urine after exposure is complex and shows a significant variability.
The case reported here showed a MPN serum concentration of 16.5 and 6.2 ng/mL after 14 and 20
hours from the exposure, respectively. These values are below the concentrations measured by other authors (usually above 100 ng/mL) but, in agreement with our data, Hasegawa et al (2006) 8 showed that a concentration of 37 ng/mL at 4 hours after the consumption of 50 ginkgo nuts was enough to induce vomiting and afebrile convulsion in a 2-year-old boy. Moreover, Kajiyama & Fjii (2002) 7 showed a very quick decrease of MPN concentration in serum: from 360 ng/mL after 9 hours from the exposure to < 15 ng/mL one hour later, indicating that the timing of sample collection could be critical in detecting the biomarker.
The variability observed in the MPN serum concentration could be justified (at least partially) by the significant difference in MPN content measured in ginkgo seeds (172.8-404.2 g/g dry weight), supporting also data reported by different authors where the number of seeds necessary to produce fatalities varied from 15 and 574. 6 According to the case described here, low values of MPN concentration can also be responsible for convulsions and adverse effects and it is known that MPN toxicity can be modulated by several factors, such as the patient's nutritional state, where a particular role can be played by the pyridoxine storage. 7 In contrast to some previous papers, MPN was not detectable in the child's urine, but the ginkgo poisoning was confirmed by the identification of ginkgolide terpenic lactones, which are considered biomarkers for the acute consumption of Ginkgo biloba derivatives. 18 The correct diagnose of ginkgo poisoning, which usually require vitanin B 6 administration 7, 8, 10, 23 , is important for suitable treatment of the patient and to avoid fatalities, so that the identification of MPN in serum or urine could be very useful. A sensitive method for the detection of this biomarker was optimized and validated specifically for the cases of poisoning by ginkgo seeds. We showed in this study that poisoning can be severe also when the level of MPN in urine is not detectable; in these cases, the identification and semi-quantitation of gikgolide terpene lactones in urine provides a valuable tool in confirming the acute consumption of ginkgo seeds. Moreover, we observed that the ratio between the three main ginkgolides (A:B:C) was approximately 1:40:2. The relative abundance of excreted ginkgolides was different from that observed by Dew et al (2014) 20 , where ginkgolide A was the most abundant terpenoid in urine after the consumption of leaf extract (109% of quantity administered). If confirmed by other studies, this specific ginkgolide relative abundance in urine, associated with the absence/very low quantity of bilobalide, could be also used to distinguish between poisoning due to ginkgo leaves and that from seeds. Finally, the case described indicates that population, family doctors, and authorities need to be informed on the specific risk deriving from food containing ginkgo, taking also into consideration the increasing diffusion worldwide of oriental cuisine.
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